DS
ABBV icon

DRW Securities’s AbbVie ABBV Stock Holding History

DRW Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,100
Closed -$8.33M – 1251
2025
Q2 		$8.33M Buy
45,100
+7,500
+20% +$1.39M 0.19% 63
2025
Q1 		$7.88M Buy
+37,600
New +$7.31M 0.22% 67
2024
Q3 		– Sell
-1,300
Closed -$223K – 547
2024
Q2 		$223K Buy
1,300
+100
+8% +$16.6K 0.01% 460
2024
Q1 		$219K Buy
+1,200
New +$207K 0.01% 327

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DRW Securities's ABBV Position: Q2 2026 in Review

DRW Securities sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,353 shares — an estimated $293K sold.

DRW Securities first reported a position in ABBV in Q1 2016 and held it in 20 quarters. The position peaked at $8.13M in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DRW Securities reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 1,353 AbbVie shares in Q2 2026, an estimated $293K.
  • DRW Securities first reported a position in AbbVie in Q1 2016 and held it in 20 quarters.
  • DRW Securities's AbbVie position peaked at $8.13M in Q1 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.